Literature DB >> 7059422

Atenolol disposition in young and elderly subjects.

P C Rubin, P J Scott, K McLean, A Pearson, D Ross, J L Reid.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7059422      PMCID: PMC1402004          DOI: 10.1111/j.1365-2125.1982.tb01364.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

1.  Metabolism of atenolol in man.

Authors:  P R Reeves; J McAinsh; D A McIntosh; M J Winrow
Journal:  Xenobiotica       Date:  1978-05       Impact factor: 1.908

2.  Kinetics and absolute bioavailability of atenolol.

Authors:  W D Mason; N Winer; G Kochak; I Cohen; R Bell
Journal:  Clin Pharmacol Ther       Date:  1979-04       Impact factor: 6.875

3.  The effect of age on plasma levels of propranolol and practolol in man.

Authors:  C M Castleden; C M Kaye; R L Parsons
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

4.  The effects of age and liver disease on the disposition and elimination of diazepam in adult man.

Authors:  U Klotz; G R Avant; A Hoyumpa; S Schenker; G R Wilkinson
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

5.  Studies on the pharmacokinetics and pharmacodynamics of atenolol in man.

Authors:  J D Fitzgerald; R Ruffin; K G Smedstad; R Roberts; J McAinsh
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

Review 6.  Pharmacokinetics in the elderly.

Authors:  J Crooks; K O'Malley; I H Stevenson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

7.  Atenolol determination by high-performance liquid chromatography and fluorescence detection.

Authors:  Y G Yee; P Rubin; T F Blaschke
Journal:  J Chromatogr       Date:  1979-04-01

8.  Prazosin disposition in young and elderly subjects.

Authors:  P C Rubin; P J Scott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

9.  Withdrawal of long-term therapy with atenolol in hypertensive patients.

Authors:  J Webster; G M Hawksworth; H E Barber; T A Jeffers; J C Petrie
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

10.  Pharmacokinetics, pharmacology of atenolol and effect of renal disease.

Authors:  S H Wan; R T Koda; R F Maronde
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

  10 in total
  14 in total

Review 1.  Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

Authors:  Arduino A Mangoni
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Steady state pharmacokinetics of hydrolysed bopindolol in young and elderly men.

Authors:  D Holmes; E Nuesch; J M Houle; J Rosenthaler
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

4.  Absorption of beta-adrenoceptor antagonists to Amberlite resin.

Authors:  A Heath; M Gabrielsson; C G Redgårdh
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

5.  A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.

Authors:  J W Rigby; A K Scott; G M Hawksworth; J C Petrie
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

6.  Pharmacokinetics of valproic acid in young and elderly subjects.

Authors:  S M Bryson; N Verma; P J Scott; P C Rubin
Journal:  Br J Clin Pharmacol       Date:  1983-07       Impact factor: 4.335

Review 7.  Physiological changes due to age. Implications for cardiovascular drug therapy.

Authors:  I Stolarek; P J Scott; F I Caird
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

8.  Atenolol elimination in the neonate.

Authors:  P C Rubin; L Butters; B Reynolds; J Evans; D Sumner; R A Low; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

Review 9.  Adverse drug reactions. An overview of special considerations in the management of the elderly patient.

Authors:  L A Brawn; C M Castleden
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

10.  Beta-blocking effect and pharmacokinetics of pindolol in young and elderly hypertensive patients.

Authors:  I Gretzer; G Alván; H Dunér; M Garle; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.